P01
pPLUS® AAV-Helper, novel engineered pHelper plasmid to improve yield and quality of several AAV serotypes in suspension cell culture systems
P02
Development of a rAAV empty to full capsid ratio quantification method by AEX-HPLC
P03
Optimization of mRNA production and purification: characterization and controlling of post-transcriptional polyadenylation
P04
From Variability to Consistency: A Novel Manufacturing System for Standardized Extracellular Vesicles from immortalized human Mesenchymal Stromal Cells
P05
Improved purification of enveloped virus-like particles (VLPs) by advanced differentiation of extracellular vesicles (EVs) and VLPs
P06
Efficient rAAV8 Capsid Quantification in Upstream Process Development with two-dimensional liquid chromatography
P07
Depletion of production-related impurities improves the performance of self-amplifying RNA
P08
Lentiviral downstream process optimisation and Design of experiments on CIM QA 0.05 mL Monolithic 96-well Plates
P09
Synthetic Enzymatically produced DNA for Gene Therapy & Vaccine Applications
P10
Advancements in adeno-associated virus bioprocess development: enhancing chromatographic strategies for efficient gene therapy production
P11
Reverse-phase chromatography removes double-stranded RNA, fragments and residual template to decrease immunogenicity and increase cell potency of mRNA and saRNA
P12
Viral vector genome integrity evaluation to support process development and comparability
P13
Monolith based chromatography is a suitable tool to prepare and analyze E. coli outer membrane vesicles
P14
Development of a full capsid enrichment polishing step in AAV9 and AAV8 purification process with CIMmultus® PrimaT monolithic column
P15
Purification of vesicular stomatitis virus (VSV) by immunoaffinity monolith chromatography with native elution
P16
Cell Type-Specific Genetic Therapy of Cancer, Virus Infection and Mitochondrial Disease
P17
Comparability Study Between Ion-Exchange Monolith and Affinity Resin for Purification of AAV8
P18
Integrated cGMP Manufacturing of mRNA: From DNA Template to Drug Product – the CDMO's Point of View
P19
Utilizing CIMmultus® OH for efficient purification of MSC Evs
P20
Chromatographic characterization of cation-exchange carboxymethyl/nanofibrilated cellulose-based membranes using lysozyme as a model protein
P21
PATfix analytical method for Orf virus sample characterization
P22
Processing CD and DSC data on protein folding with Zimm-Bragg model in water
P23
2D-LC evaluation of complex samples containing extracellular vesicles
P24
Grafting chromatographic monoliths with charged linear polymers for highly productive and selective plasmid DNA purification
P25
High Reproducibility, Homogeneity, and Scalability of CIM® QA HR Chromatographic Monoliths Demonstrated by Separation of Empty and Full AAV Capsids
P26